Orofacial granulomatosis (OFG), also known as Melkersson-Rosenthal syndrome, Cheilitis Granulomatosis, and Schuermann's Glossitis Granulomatosa, is an uncommon inflammatory condition effecting the face and lips. People of all ages can be affected, but it is most common in the early adult years.
Orofacial granulomatosis (OFG) is an inflammatory disease
In Orofacial granulomatosis (OFG) swelling and inflammation is seen in involved tissues, with clumps of many different types of white cells. While inflammation has been blamed on various infections from time to time, there is no definite proof that OFG is due to any one infectious organism. The cause of OFG is unknown.
Lip swelling is common
Lip swelling may initially only last a few hours at a time, and can be difficult to distinguish from another type of lip swelling known as angioedema. As the condition progresses, swelling tends to last for days at a time, and eventually becomes permanent. Sometimes cracking and dryness of the lips occurs.
Other common symptoms
Swelling of the face and eyes also occurs. Some effected individuals have a fissured tongue, and may sometimes develop facial paralysis. Mouth ulcers and inflammation of the gums, known as gingivitis is sometimes seen. Other symptoms include tongue swelling or a sensation of a burning tongue. Occasionally facial numbness, cheek and gum swelling can develop.
Confirming the diagnosis
As there are many possible causes of lip swelling, tests are often required to prove the diagnosis, and to exclude diseases that can mimic OFG. These tests may include blood tests, taking a sample of the involved tissue (biopsy), or sometimes x-rays or other specialized tests.
Sometimes swellings will resolve spontaneously without treatment, but most persist for many years. While no one treatment is always effective, a number of options are available. These include:
- Elimination diets
- Medications that reduce inflammation
- Plastic Surgery.
© ASCIA 2010
The Australasian Society of Clinical Immunology and Allergy (ASCIA) is the peak professional body of Clinical Immunologists and Allergists in Australia and New Zealand.
Postal address: PO Box 450 Balgowlah, NSW Australia 2093
This document has been developed and peer reviewed by ASCIA members and is based on expert opinion and the available published literature at the time of review. Information contained in this document is not intended to replace medical advice and any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner. The development of this document is not funded by any commercial sources and is not influenced by commercial organisations.
Content updated January 2010